71 studies found for:
P-glycoprotein
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
|
||||
| 2 | Completed |
Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics
|
||||
| 3 | Completed |
Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet
|
||||
| 4 | Unknown † |
P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy.
|
||||
| 5 | Recruiting |
PET Imaging of P-glycoprotein Function Using [11C]dLop
|
||||
| 6 | Completed |
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
|
||||
| 7 | Terminated |
(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
|
||||
| 8 | Recruiting |
Efavirenz and Ritonavir on Human Brian P-Glycoprotein
|
||||
| 9 |
Completed
Has Results |
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
|
||||
| 10 | Completed |
P-glycoprotein Function in Brain Diseases
|
||||
| 11 |
Completed
Has Results |
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
|
||||
| 12 | Completed |
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
|
||||
| 13 | Completed |
Vinorelbine and XR9576 to Treat Cancer
|
||||
| 14 | Recruiting |
Brain P-gp and Inflammation in People With Epilepsy
|
||||
| 15 |
Completed
Has Results |
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
|
||||
| 16 |
Completed
Has Results |
The Role of P-glycoprotein in Sitagliptin Clinical Pharmacology
|
||||
| 17 | Completed |
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833
|
||||
| 18 | Completed |
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
|
||||
| 19 | Completed |
The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients
|
||||
| 20 | Recruiting |
Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot
|
† Indicates status has not been verified in more than two years
